On Invalid Date, 111 (NASDAQ: YI) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total 111 earnings for the quarter were -$16.42 million. In the same quarter last year, 111's earnings per share (EPS) was -$0.21.
On Invalid Date, 111 (NASDAQ: YI) reported Q4 2022 revenue of $595.16 million up 10.06% year over year. In the same quarter last year, 111's revenue was $540.76 million.
What was YI's revenue growth in the past year?
As of Q2 2023, 111's revenue has grown -0.12% year over year. This is 1.52 percentage points higher than the US Pharmaceutical Retailers industry revenue growth rate of -1.64%. 111's revenue in the past year totalled $1.96 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.